Losartan Potassium & Hydrochlorthiazide Tab 30
PHARMAC award the Tender for the above stated product on 30 September 2017.
The price ex manufacturer will reduce to $1.88 in the Pharmaceutical Schedule from 1 April 2018. However due to the way in which the tender was made there will be no price support from the supplier. They will make this price available to wholesalers from 1 March 2018 (1 month preceding the change)
This process is much more difficult for all to manage as we must ensure continuity of supply and also ensure no one within the supply chain carries any additional burden of loss.
There is one further matter which we need to advise relating to this product.
There is to be a change to the ex-manufacturer price and funding in the Pharmaceutical Schedule from the 1st February 2018.
Price will increase temporarily to $15.25
We advise you to manage your stock very well, thus avoiding any potential loses being incurred.
Please do not stock pile as this could prove very costly if mis-managed.
We thank you in anticipation of your ongoing support.